Efficacy of Treatment with Angiotensin II Receptor Antagonist Losartan in Patients with Isolated systolic Hypertension and Reduced Left Ventricular Systolic Function Taking Angiotensin-Converting Enzyme Inhibitor Lisinopril

被引：0
|
作者：
Vatinian, Susanna
Gurgenyan, Svetlana
Nikoghosyan, Karine
机构：
来源：
CIRCULATION | 2010年 / 122卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P876
引用
收藏
页码：E267 / E267
页数：1
相关论文
共 50 条
  • [1] Postoperative treatment with angiotensin-converting enzyme inhibitors in patients with preoperative reduced left ventricular systolic function
    Villacorta, Judith
    Oddoze, Chistiane
    Giorgi, Roch
    Kerbaul, Francois
    Bonnet, Marc
    Collart, Frederic
    Gouin, Francois
    Guidon, Catherine
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2008, 22 (02) : 187 - 191
  • [2] Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome
    Kosmadakis, George
    Filiopoulos, Vasileios
    Georgoulias, Christodoulos
    Tentolouris, Nicolaos
    Michail, Spiridon
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2010, 44 (04): : 251 - 256
  • [3] Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril
    Black, HR
    Graff, A
    Shute, D
    Stoltz, R
    Ruff, D
    Levine, J
    Shi, Y
    Mallows, S
    JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (08) : 483 - 489
  • [4] Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction
    Sander, GE
    McKinnie, JJ
    Greenberg, SS
    Giles, TD
    PROGRESS IN CARDIOVASCULAR DISEASES, 1999, 41 (04) : 265 - 300
  • [5] Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril
    HR Black
    A Graff
    D Shute
    R Stoltz
    D Ruff
    J Levine
    Y Shi
    S Mallows
    Journal of Human Hypertension, 1997, 11 : 483 - 489
  • [6] Comparative effects of the angiotensin-converting enzyme inhibitor perindopril and the angiotensin II receptor antagonist losartan on left-ventricular and right-ventricular hypertrophy and diastolic function in essential hypertension
    Vatinyan, SKH
    Gurgenyan, SV
    Sahakyan, KR
    Nikogosyan, KG
    Edilyan, LB
    Chobanyan, BG
    EUROPEAN HEART JOURNAL, 2003, 24 : 580 - 580
  • [7] Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitors in Patients With Left Ventricular Systolic Dysfunction and Hyponatremia
    Balling, Louise
    Kober, Lars
    Schou, Morten
    Torp-Pedersen, Christian
    Gustafsson, Finn
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (11) : 725 - 730
  • [8] Comparison Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Unstable Angina with Preserved Left Ventricular Systolic Function
    Xiao, Jiong
    Liu, Linze
    Lin, Wenhua
    ANGIOLOGY, 2023, 74 (09) : 840 - 847
  • [9] Use and benefit of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in senior patients with left ventricular systolic dysfunction
    Lopez Castillo, M.
    Cortes Garcia, M.
    Martin Mariscal, M.
    Garcia Ropero, A.
    Romero Daza, A.
    Palfy, J. A.
    Briongos Figuero, S.
    Farre Muncharaz, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 50 - 50
  • [10] Effectiveness of treatment with angiotensin-converting enzyme inhibitor perindopril and angiotensin II receptor antagonist eprosartan in postmenopausal hypertensive women with asymptomatic systolic dysfunction
    Vatinian, S.
    Gurgenyan, S.
    Nikoghosyan, K.
    JOURNAL OF HYPERTENSION, 2008, 26 : S517 - S517
12345